Project Grant R43HL144352

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...

Federal Grant Award Summary Nimble Surgical Incorporated received a $314,362 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) beginning September 15, 2025, and concluding September 14, 2026. The company will develop and advance the FLEXLOCK guide catheter, a manually operable anchoring guide catheter designed to simplify transradial complex percutaneous coronary interventions (PCIs). This novel...

Sirona Medical Technologies, Inc. received a $323,230 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), with performance in Connecticut. The award, obligated on May 15, 2025 with a completion date of March 31, 2026, supports development of a multi-channel radiofrequency and pulsed field energy source generator for cardiac ablation procedures. This generator is designed to deliver customizable,...

Federal Project Grant Award Summary Perfusion Solutions Inc. received a $320,838 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 5, 2025, with completion targeted for February 28, 2027. The award supports Phase I development of a fail-safe, high-output cavopulmonary assist pump designed for pediatric and congenital heart disease patients with single ventricle physiology...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $366,006 Project Grant (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Georgia Tech Research Corporation to develop flexible piezo film intravascular ultrasound (IVUS) arrays on guidewires and catheters. The goal is to integrate IVUS imaging capability onto standard guidewires and catheters used in over 1 million percutaneous coronary and peripheral...

Corveus Medical, Inc. was awarded a $255,841 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an extravascular bipolar catheter for targeted nerve ablation with minimal collateral damage to surrounding tissues. The grant aims to support the design and prototyping of a minimally invasive, catheter-delivered venous procedure for performing extravascular greater splanchnic nerve ablation. The proposed catheter...

RCE Technologies, Inc. was awarded a $255,892 Small Business Innovation Research Phase I Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program to develop a proof-of-concept machine learning-based diagnostic system for detecting myocardial infarction and ischemia in real-time. The system aims to provide point-of-care clinical classification for heart attack cases using a novel, portable device integrating the awardee's proprietary external...

Federal Project Grant Award Summary Georgia TECH Research Corp received a $603,818 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective April 1, 2026, with completion anticipated by March 1, 2030. The awardee will develop and demonstrate a 2.5 French combined intravascular ultrasound (IVUS) and fractional flow reserve (FFR)...

This $696,259 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research integrating flexible electronics and optogenetics to enable real-time arrhythmic profiling of engineered heart tissues. Awarded to Northwestern University's Sponsored Research Division on June 1, 2026, with completion targeted for April 30, 2031, the project addresses critical limitations in current cardiac disease modeling by...

Federal Project Grant Award Summary Aptus, LLC received a $965,037 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) awarded September 1, 2025, with completion anticipated August 31, 2027. The project deliverables focus on the development and preclinical testing of an expandable pediatric pulmonary heart valve designed to address a critical clinical gap in congenital heart valve disease treatment....